Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes in Pretreated Patients with Metastatic Cancer By Ogkologos - October 14, 2025 126 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROME study Source RELATED ARTICLESMORE FROM AUTHOR The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer ESMO Welcomes Launch of Health Package Introducing EU Measures That Can Boost Innovation in Oncology and Help Prevent New Cancer Cases MOST POPULAR Taking on DNA repair to tackle cancer November 5, 2021 “That is what I dream”: India’s journey to rolling out the... November 17, 2021 Aiming to Prevent Cancer Cases, ESMO Calls Against Misleading Alcohol-Labelling Following... December 3, 2025 TAT 2021 Honorary Award: A Recognition in Cancer Drug Development to... February 16, 2021 Load more HOT NEWS Holidays, Traditions and Grief The team tackling the serious side effects of cancer treatment in... 7 Steps for Developing Microhabits During Cancer That Can Improve Your... Long-Term Outcomes in Patients with Metastatic Melanoma Treated with Anti-PD1 Therapy...
